Skip to main content
OpenTrials
Completed

NCT Number: NCT04485754

Telemedicine Follow-up for Post-ACS Patients

The aim is to compare the safety of using telemedicine and office visit follow-up in post-acute coronary syndrome patients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

ACS - Acute Coronary Syndrome Acute Coronary Syndrome Cardiovascular Diseases Heart Diseases Myocardial Ischemia Vascular Diseases

Age range

40 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science

Tyumen, 625026, Russia

About this study

Rehabilitation after acute coronary syndrome includes visits to the cardiologist's office at 1, 2, 6 and 12 months after discharge. Due to the Covid-19 pandemic, visiting a cardiologist's office maybe impossible. In such cases telemedicine follow-up visit would be reasonable choice. Taking into account the absence of studies in this area, providing investigation evaluating parameters of safety for both methodics is relevant.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Signed informed consent
  • Age ≥ 40 years
  • PCI with coronary artery stenting for ACS
  • Angiographic success PCI

Exclusion criteria

  • Patients with cancer
  • Severe CHF (EF LV <35% or functional class of heart failure III-IV NYHA)
  • Severe valvular heart disease or Prosthetic heart valves.
  • Severe forms of CKD (GFR<30mL/min)
  • Planned staged revascularization during the next 12 months
  • Planned surgery within the next 12 months

Treatment and study plan

Telemedicine FU

Other

Participant will get telemedicine follow-up visit at 1, 3, and 6 months or 1 and 6 months after discharge from hospital.

Office FU

Other

Participant will get office follow-up visit at 1, 3, and 6 months or 1 and 6 months after discharge from hospital.

Primary outcomes

  1. MACCE

    Time frame: 1 year

    Major adverse cardiac and cerebrovascular events: cardiac death, myocardial infarction, or stroke

Secondary outcomes

  1. High level of MT optimization

    Time frame: 1 year

    High Level of Medical Therapy Optimization is defined as a participant meeting all of the following goals: LDL < 1.4 mmol/L and on any statin, blood pressure < 140/90 mm/Hg (<135/85 mm/Hg for patients with diabetes mellitus), on aspirin or other antiplatelet or anticoagulant, and not smoking. High level of medical therapy optimization is missing if any of the individual goals are missing.

  2. PB < 140/90 mm/Hg (<135/85 mm/Hg for Diabetes)

    Time frame: 1 year

    Blood pressure < 140 mm/Hg (<135/85 mm/Hg for for patients with diabetes mellitus)

  3. LDL < 1.4 mmol/L

    Time frame: 1 year

    Low density lipoprotein< 1.4 mmol/L

  4. Not smoking

    Time frame: 1 year

    Not smoking

  5. Decrease in overweight

    Time frame: 1 year

    Decrease in overweight

  6. Aspirin or other antiplatelet or anticoagulant

    Time frame: 1 year

    Adherence to aspirin or other antiplatelet or anticoagulant

  7. Adherence to prescribed medication

    Time frame: 1 year

    Adherence to prescribed at discharge medication

  8. Hospitalization

    Time frame: 1 year

    Hospitalization for cardiac reasons

Sponsors and collaborators

Lead sponsor

Tomsk National Research Medical Center of the Russian Academy of Sciences

Other

Registry information

Official study title

Telemedicine Follow-up for Post-Acute Coronary Syndrome Patients

Important dates

Study start
2020
Primary completion
2020
Study completion
2021
First posted
Jul 24, 2020
Registry last updated
Jun 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.